Skip to contentS
Strata Critical Medical, Inc.
S
SRTAStrata Critical Medical, Inc. Q3 2025 · 10-Q
Revenue$49.30M$49.30M+36.7% vs Q3 2024 Net Income$57.42M$57.42MN/M vs Q3 2024 EPS Diluted$0.70$0.70N/M vs Q3 2024 Operating Income-$5,622,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Strata Critical Medical, Inc. · CIK 1779128 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$40,195,000N/M Margins · derivedOperating margin-11.4%+8.3 pt vs Q3 2024
Net margin116.5%+121.9 pt vs Q3 2024
ended Sep 30, 2025 · filed Nov 10, 2025 · 41 d after period end